Detalles de la búsqueda
1.
Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.
Int J Urol
; 30(1): 57-61, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513615
2.
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Int J Urol
; 30(9): 730-736, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575640
3.
Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Jpn J Clin Oncol
; 52(8): 944-949, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462401
4.
Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
Jpn J Clin Oncol
; 52(3): 274-280, 2022 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994772
5.
Comparison of perioperative outcomes among patients with exophytic, mesophytic, and endophytic renal tumors undergoing robot-assisted partial nephrectomy.
Int J Urol
; 29(9): 1026-1030, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35669994
6.
Limited impact of erectile function on health-related quality of life in Japanese men undergoing robot-assisted radical prostatectomy.
Int J Urol
; 29(9): 956-961, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176812
7.
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.
Int J Urol
; 29(5): 398-405, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080069
8.
Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association.
Int J Urol
; 29(8): 780-792, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643932
9.
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer.
Cancer Sci
; 112(9): 3616-3626, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34145921
10.
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
Cancer Sci
; 112(4): 1524-1533, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159829
11.
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.
Int J Clin Oncol
; 26(9): 1745-1751, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255227
12.
Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
Jpn J Clin Oncol
; 50(6): 718-721, 2020 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32322885
13.
Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
Jpn J Clin Oncol
; 50(1): 12-19, 2020 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633185
14.
Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Qual Life Res
; 29(3): 755-763, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583618
15.
Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.
Jpn J Clin Oncol
; 49(8): 772-779, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30977820
16.
Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
Qual Life Res
; 28(9): 2383-2391, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31025290
17.
Significant impact of three-dimensional volumetry of perinephric fat on the console time during robot-assisted partial nephrectomy.
BMC Urol
; 19(1): 132, 2019 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31830961
18.
Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer.
Int J Clin Oncol
; 24(7): 842-847, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739263
19.
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
Int J Clin Oncol
; 24(5): 557-566, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30875000
20.
No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer.
Int J Clin Oncol
; 23(3): 576-583, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29275450